Rx Medicare

Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) (“Biostar” or “the Company”), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions announced that the Chinese Military Drug Administration has granted clearance to begin clinical trials on the Company’s new drug application, the Zushima Analgesic Aerosol Spray.

Read More…

Related Posts

• MicroTransponder Raises $10 Million To Begin Clinical Trials Of Wireless Neurostimulation For Chronic Pain And Obtain FDA Clearance
• Medicago Receives Regulatory Approval To Begin Human Clinical Testing With Its Avian Flu Pandemic Vaccine
• Funxional Successfully Completes Initial Clinical Trial Of FX125L, An Anti-Inflammatory Drug With A Novel Mechanism Of Action
• Xanodyne Receives Approval From The U.S. Food And Drug Administration For ZIPSOR(TM) (diclofenac Potassium) Liquid Filled Capsules
• MAP Pharmaceuticals Announces Completion Of Enrollment In Phase 3 Clinical Trial Of MAP0004 In Patients With Migraine
• Javelin Pharmaceuticals’ Receives FDA PDUFA Date For Dyloject™ NDA
• Amarillo Biosciences Announces Australian Phase 2 Oral Interferon Clinical Trial Indicates Benefit In Preventing Influenza-Like Illness In Seniors
• Clinical Trial: Miniature Ultrasound Device Could Revolutionize Pain Relief
• Third Party Reexamination Of Javelin Pharmaceuticals’ Phase III Trial Data For Ereska Yields Statistically Significant Primary Endpoint
• Trigemina Conducting Phase IIa Clinical Trial In Chronic Daily Headache
• China Aoxing Pharmaceutical Company Announces Successful Completion Of Phase II Clinical Study Of Novel Menstrual Pain Drug
• CNSBio Inc. To Present Latest Clinical Trial Data For CNSB015 At Neuropathic Pain Conference In San Francisco
• Winston Laboratories, Inc. Announces Positive Top-line Results Of Phase II Clinical Trial Of Civamide Patch
• Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review For Intravenous Acetaminophen By Three Months
• APP Pharmaceuticals Receives Approval For Sumatriptan Succinate Injection, USP

Tags: administration, aerosol, analgesic, begin, biostar, chinese, clearance, clinical, drug, military, pharmaceuticals, receives, spray, trial, zushima

This entry was posted on Sunday, October 11th, 2009 at 10:10 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.